Showing results (1-10 of 10,308) with videos related to
Sort By:
Pageof 1,031
Circulation|June 1, 1982
Drug-induced conditioning in congestive heart failureC V Leier, P Huss, R P Lewis, et al.Zeitschrift Fur Kardiologie|January 1, 1983
Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administrationC V Leier, P Huss, R D Magorien, et al.Circulation|April 1, 1983
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failureC V Leier, P Huss, R D Magorien, et al.Pharmacotherapy|January 1, 1986
The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failureC V Leier, J H Ren, P Huss, et al.Clinical Pharmacology and Therapeutics|September 1, 1980
Hemodynamic effects of intravenous butopamine in congestive heart failureM J Thompson, P Huss, D V Unverferth, et al.The American Journal of the Medical Sciences|September 1, 1986
The hemodynamic and clinical responses to terazosin, a new alpha blocking agent, in congestive heart failureC V Leier, S E Patterson, P Huss, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Preliminary observations of chronic indoramin therapy in congestive heart failureC V Leier, P Huss, D Parrish, et al.Annals of Internal Medicine|October 1, 1983
Drugs five years later. DobutamineC V Leier, D V UnverferthInternational Journal of Clinical Pharmacology Research|January 1, 1984
Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal studyJ R Evans, K Pacht, P Huss, et al.Cardiovascular Drugs and Therapy|January 1, 1988
Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failureA P Good, D V Unverferth, C V LeierPageof 1,031